HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Congress Senate Washington D.C. DC
Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

lung cancer screening
Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

Ct scanning room with X-ray radiation warning sign above the door at Wellstar Kennestone Hospital. Photo by Dave Fornell
High-dose CT scans have significantly increased in recent years

Despite numerous advances in scanner technology, many patients are being exposed to higher amounts of radiation during CT exams than in the past. 

The Biden administration will fight back and appeal a ruling that overturned the federal mask mandate on airlines and public transportation.
COVID significantly increases risk of death from metastatic cancer, new study shows

Viruses like COVID-19 and the flu could awaken dormant cancer cells that have previously spread to the lungs, triggering growth of metastatic disease.

the words "FDA recall" on a board
FDA announces recall of imaging systems that have the 'potential to produce fire'

Philips North America recently issued a series of urgent recalls, which pertain to thousands of the company's medical imaging machines. 

MRI biomarkers predict cognitive impairment post-stroke
MRI biomarker could identify patients at risk of cognitive decline post-stroke

A new study’s findings highlight the potential for imaging biomarkers to help guide post-stroke care decisions in the future. 

MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.
New details surrounding fatal Long Island MRI accident prompt more questions

New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 

WashU AI device earns FDA's Breakthrough Device designation.
'Revolutionary' AI risk assessment tool earns FDA's Breakthrough Device designation

The technology is said to be twice as accurate at predicting five-year cancer risk compared to current risk assessment methods.

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.